Assistant Vice President Health Outcomes
Prime Therapeutics, LLC
As Senior Director, Health Outcomes at Prime Therapeutics, Dr. Gleason leads Prime’s clinical health outcomes assessment team in the development and improvement of pharmacy benefit management programs. Through integrated medical and pharmacy claims data analysis, Dr. Gleason assesses clinical program opportunity and post-implementation outcomes.
Dr. Gleason is an Adjunct Professor of Pharmacy at the University of Minnesota, College of Pharmacy. He is a Board Certified Pharmacotherapy Specialist (BCPS), an elected Fellow of the Academy of Managed Care Pharmacy (FAMCP), as well as an elected Fellow of the American College of Clinical Pharmacy (FCCP).
He has over 40 peer-reviewed publications in medical and health policy journals such as Health Affairs, Journal of Managed Care Pharmacy (JMCP), Medical Care, Archives of Internal Medicine, and JAMA.